6/27/24 20:00 | 6/26/24 | KALA | Kala Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bazemore Todd | MA | O | SEE REMA | S | -22 | 4.75 | 0 | -5 | -5 | 83 | D | | | | | | | | | | | | | | |
6/3/24 20:00 | 5/31/24 | KALA | Kala Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bazemore Todd | MA | O | SEE REMA | S | -13 | 6.09 | 0 | -2 | -2 | 88 | D | | | | | | | | | | | | | | |
1/5/24 16:03 | 1/4/24 | KALA | Kala Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bazemore Todd | MA | O | SEE REMA | S.d | -9 | 6.74 | 0 | -1 | -100 | 0 | D | | | | | | | | | | | | | | |
1/6/23 20:00 | 1/4/23 | KALA | Kala Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bazemore Todd | MA | O | SEE REMA | S | -2 | 28.54 | 0 | 0 | 0 | 15 | D | | | | | | | | | | | | | | |
10/28/22 16:15 | 10/26/22 | KALA | Kala Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bazemore Todd | MA | O | SEE REMA | S | -1 | 6.51 | 0 | 0 | -9 | 2 | D | | | | | | | | | | | | | | |
6/29/22 20:10 | 6/27/22 | KALA | Kala Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bazemore Todd | MA | O | SEE REMA | S | -1 | 0.3700 | 0 | -3 | -3 | 116 | D | | | | | | | | | | | | | | |
1/5/22 20:00 | 1/4/22 | KALA | Kala Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bazemore Todd | MA | O | SEE REMA | S.d | -4 | 1.30 | 0 | -3 | -3 | 119 | D | | | | | | | | | | | | | | |
10/28/21 20:03 | 10/26/21 | KALA | Kala Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bazemore Todd | MA | O | COO | S | -23 | 1.80 | 0 | -13 | -9 | 122 | D | | | | | | | | | | | | | | |
6/29/21 17:25 | 6/28/21 | KALA | Kala Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bazemore Todd | MA | O | COO | S | -17 | 5.77 | 0 | -3 | -99 | 0 | D | | | | | | | | | | | | | | |
10/28/20 20:36 | 6/5/20 | KALA | Kala Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bazemore Todd | MA | O | COO | P.m | 0 | 7.88 | 0 | 0 | 0 | 110 | M | | | | | | | | | | | | | | |
3/17/20 17:46 | 3/16/20 | KALA | Kala Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bazemore Todd | MA | O | COO | P | 58 | 5.75 | 0 | 10 | New | 10 | D | | | | | | | | | | | | | | |
8/19/15 16:18 | 8/18/15 | DYAX | Dyax Corp | DE | Health | Biolab | Commercial Physical & Biologi | Bazemore Todd | MA | O | EVP,Chie | M.d | 94 | 6.80 | 22 | 14 | New | 14 | D | 469 | 136 | 52 | -13 | -10 | -4 | -3 | 4 | -5 | -6 | 7 | 48 | | |
8/6/15 16:35 | 8/4/15 | DYAX | Dyax Corp | DE | Health | Biolab | Commercial Physical & Biologi | Bazemore Todd | MA | O | EVP,Chie | M.dm | 292 | 6.80 | 23 | 43 | | 0 | D | 468 | 148 | 60 | -9 | -11 | -14 | -5 | -5 | 7 | 5 | -1 | 57 | | |
8/6/15 16:35 | 8/4/15 | DYAX | Dyax Corp | DE | Health | Biolab | Commercial Physical & Biologi | Bazemore Todd | MA | O | EVP,Chie | S.dm | -1,016 | 23.62 | 23 | -43 | -100 | 0 | D | 468 | 148 | 60 | -9 | -11 | -14 | -5 | -5 | 7 | 5 | -1 | 57 | | |